Skip to Content
 

News: Research

Diabetes drug may prevent cancer

Friday, September 21st, 2018

A drug commonly used to treat type 2 diabetes might help prevent patients from developing liver cancers, according to a recent study by Harvey J. Murff, MD, MPH, and colleagues.

Study tracks incidence, timing of immunotherapy-related deaths

Thursday, September 13th, 2018

Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

Using light to fight GVHD

Tuesday, September 4th, 2018

Vanderbilt investigators have conducted a prospective multicenter study on how extracorporeal photopheresis works in treating chronic graft-versus-host disease (cGVHD) — a complication of bone marrow or stem cell transplant that occurs when donor cells attack the recipient.

Energetic gene switch

Tuesday, September 4th, 2018

Vanderbilt researchers have identified a previously undetected type of histone modification that may have implications for cancer and other conditions.

A brain-builder called “Shh”

Tuesday, September 4th, 2018

The Sonic hedgehog protein plays a crucial role in the development of brain cells that may be the source of some types of pediatric brain tumors, a recent study reports.

A new target for lung cancer

Tuesday, August 21st, 2018

A recent study suggests that a transporter protein called xCT may be potential therapeutic target in lung cancer.

Genetic balancing act

Friday, August 3rd, 2018

A recent study showing that protein called RADX helps regulate the process of DNA repair may help us better understand why some cancers are more or less resistant to certain therapies

Fueling the MATE transporter

Friday, August 3rd, 2018

A recent study on how cellular proteins known as “multidrug transporters” work may inform the development of novel anti-cancer and anti-bacterial drugs that can overcome resistance.

SMAD4 clue to colon cancer

Friday, July 6th, 2018

A recent study has linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.

Team identifies new gene candidates for breast cancer risk

Monday, July 2nd, 2018

A new study has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer.

Next Page »